Skip to main content
ATRA logo

ATRA

Atara Biotherapeutics, Inc.
$11.65 +0.28 (+2.46%) At close · Jul 2
Market Cap
$104.97M
Shares
9,010,172

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 34
Total Value: $12,129,896
Total Shares: 2,564,431

Institutional Ownership Trend

9 quarters

Holder Concentration

Across 34 13F filers
Top Holder
27.3%
Jun 2024 → Mar 2026 · range 17.0% – 31.8%
of institutional value
Top 5
72.8%
Jun 2024 → Mar 2026 · range 55.6% – 76.2%
of institutional value
Top 10
89.4%
Jun 2024 → Mar 2026 · range 77.8% – 90.9%
of institutional value
HHI
1,396
Jun 2024 → Mar 2026 · range 848 – 1,822
Broadly held
Showing 34 of 34
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1604464 CUSIP 046513206 13F (30d) 1 filings 1 filers Visit website Investor relations